Effects of SGLT2 inhibitors on haematocrit and haemoglobin levels and the associated cardiorenal benefits in T2DM patients: A meta‐analysis

Journal of Cellular and Molecular Medicine

Jiayi Deng¹  Yanjun Zhong¹  Lin Yang²  Keyu Guo²  Qi Tian² 

[1] ICU Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China;National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China;

关键词: cardiorenal protection;    haematocrit;    haemoglobin;    meta‐analysis;    SGLT2 inhibitors;    type 2 diabetes mellitus;   

DOI  :  10.1111/jcmm.17115

来源: Wiley

【 授权许可】

CC BY